Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

How CRISPR and AI Destroy the World Imagine a world where the genetic code is as easy to edit as a simple copy-and-paste.

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

NHS officials estimate that around 50 people a year will receive treatment now that it has been approved for use for certain ...